Sandbox/20: Difference between revisions
< Sandbox
Line 15: | Line 15: | ||
|style="width:35%"|'''Alternative Regimen''' | |style="width:35%"|'''Alternative Regimen''' | ||
|- | |- | ||
| '''''Preterm—1 mo''''' || '''''[[Streptococcus agalactiae]]''''' (49%) <BR> '''''[[Escherichia coli]]''''' (18%) <BR> '''''misc. Gram-positive''''' (10%) <BR> '''''misc. Gram-negative''''' (10%) <BR> '''''[[Listeria]]''''' (7%) || ''''' | | '''''Preterm—1 mo''''' || '''''[[Streptococcus agalactiae]]''''' (49%) <BR> '''''[[Escherichia coli]]''''' (18%) <BR> '''''misc. Gram-positive''''' (10%) <BR> '''''misc. Gram-negative''''' (10%) <BR> '''''[[Listeria]]''''' (7%) || '''''[[Ampicillin]]''''' <BR> ''PLUS'' <BR> '''''[[Cefotaxime]]''''' <BR> (for dosage see footnote) || '''''[[Ampicillin ]]''''' <BR> ''PLUS'' <BR> '''''[[Gentamicin]]''''' <BR>(for dosage see footnote) | ||
|- | |- | ||
| '''''1 mo—50 yrs''''' || '''''[[Streptococcus pneumoniae]] <BR> [[Neisseria meningitidis]] <BR> [[Haemophilus influenzae]]<sup>†</sup> || '''''[[Cefotaxime]] 2 gm IV q4—6h''''' ''OR'' '''''[[Ceftriaxone]] 2 gm IV q12h''''' <BR> ''PLUS'' <BR> '''''[[Vancomycin]] 500—750 mg IV q6h'''''<sup>‡</sup> <BR> ''PLUS'' <BR> '''''[[Dexamethasone]]''''' || | | '''''1 mo—50 yrs''''' || '''''[[Streptococcus pneumoniae]] <BR> [[Neisseria meningitidis]] <BR> [[Haemophilus influenzae]]<sup>†</sup> ||'''''Adult dosage:'''''[[Cefotaxime]] 2 gm IV q4—6h''''' ''OR'' '''''[[Ceftriaxone]] 2 gm IV q12h''''' <BR> ''PLUS'' <BR> '''''[[Vancomycin]] 500—750 mg IV q6h'''''<sup>‡</sup> <BR> ''PLUS'' <BR> '''''[[Dexamethasone]]''''' ''<BR> ''''''Peds:''''''[[Cefotaxime]]''''' 200 mg/kg per day IV div. q6–8h; [[Ceftriaxone]] 100 mg/kg per day IV div. q12h; [[Vancomycin]] 15 mg/kg IV q6h.||''''' [[Meropenem]]2 gm IV q8h''''' <BR> ''PLUS'' <BR>'''''[[Vancomycin]]''''' <BR> ''PLUS'' <BR>'''''IV [[Dexamethasone ]] | ||
|- | |- | ||
| '''''1.>50 yrs 2.alcoholism 3.debilitating assoc diseases 4.impaired cellular immunity''''' || | | '''''1.>50 yrs 2.alcoholism 3.debilitating assoc diseases 4.impaired cellular immunity''''' || '''''[[Streptococcus pneumoniae ]]'''''<BR>'''''[[listeria]]'''''[[Gram-negative|Gram-negative bacilli]]''''' ||'''''[[Ampicillin]] 2 gm IV q4h ''''' <BR> ''PLUS''<BR>''''''[[Ceftriaxone]] 2 gm IV q12h''''' OR '''''[[Cefotaxime]] 2 gm IV q6h''''' <BR> ''PLUS'' <BR> '''''[[Vancomycin]]'''''<BR> ''PLUS'' <BR>'''''IV [[Dexamethasone ]]''''' | ||
|| '''''[[Meropenem]] 2 gm IV q8h''''' <BR> ''PLUS''<BR> '''''[[Vancomycin]]''''' <BR> ''PLUS'' <BR> IV '''''[[Dexamethasone ]]''''' | |||
|- | |||
| '''''Post-neurosurgery, post-head trauma, or post-cochlear implant || '''''[[Streptococcus pneumoniae]] most common, esp. if CSF leak.'''''<BR>Other: [[Staphylococcus aureus]], coliforms, [[Pseudomonas aeruginosa]]||'''''Vancomycin (until known not MRSA) 500–750 mg IV q6h2''''''<BR> ''PLUS'' <BR> '''''[[Cefepime]] or [[Ceftazidime]] 2 gm IV q8h'''''||'''''[[Meropenem]] 2 gm IV q8h'''''<BR> ''PLUS'' <BR> '''''[[Vancomycin]]1 gm IV q6–12h ''''' | |||
|- | |||
| Ventriculitis/meningitis due to infected ventriculo-peritoneal (atrial) shunt||'''''[[Staphylococcus epidermidis]],'''''[[Staphylococcus aureus]],'''''coliforms,diphtheroids (rare),''''''[[Propionibacterium acnes]]'''''||'''''[[Vancomycin]] 500–750 mg IV q6h '''''<BR> ''PLUS''<BR> '''''[[cefepime]]''''' ''or'' '''''[[ceftazidime]] 2 gm IV q8h'''''||'''''[[Vancomycin]]''''' 500–750 mg IV q6h''''' <BR> ''PLUS'' <BR>'''''[[Meropenem]]''''' 2 gm IV q8h ''''' | |||
|- | |- | ||
|} | |} | ||
<sup>†</sup> H. influenzae now very rare, listeria unlikely if young & immuno-competent (add ampicillin if suspect listeria: 2 gm IV q4h) | <sup>†</sup> H. influenzae now very rare, listeria unlikely if young & immuno-competent (add ampicillin if suspect listeria: 2 gm IV q4h) | ||
<sup>‡</sup> Children’s dosage 15 mg/kg IV q6h (2x standard adult dose) | <sup>‡</sup> Children’s dosage 15 mg/kg IV q6h (2x standard adult dose). In adults, max dose of 2-3 gm/day is suggested: 500–750 mg IV q6h. | ||
====Postive CSF Gram Stain==== | |||
{| class="wikitable" border="1" style="background:Snow; font-size:85%;" | |||
|- | |||
|style="width:10%"|'''Group''' | |||
|style="width:20%"|'''Etiology''' | |||
|style="width:35%"|'''Preferred Regimen''' | |||
|style="width:35%"|'''Alternative Regimen''' | |||
|- | |||
| '''''Gram-positive diplococci''''' || '''''[[S.pneumoniae]]''''' ||'''''[[Ceftriaxone]] 2 gm IV q12h''''' ''OR'' ''''' [[Cefotaxime]] 2 gm IV q4–6h''''' <BR> ''PLUS'' <BR> '''''[[Vancomycin]] 500–750 mg IV q6h''''' <BR> ''PLUS'' <BR> '''''timed [[Dexamethasone]] 0.15 mg/kg q6h IV x 2–4 days || '''''[[Meropenem]] 2 gm IV q8h''''' ''OR'' '''''[[Moxifloxacin]] 400 mg IV q24h''''' | |||
|- | |||
| '''''Gram-negative diplococci ''''' || '''''[[N. meningitidis]]'''''||'''''[[Cefotaxime]] 2 gm IV q4–6h''''' ''OR'' '''''[[Ceftriaxone]] 2 gm IV q12h'''''||'''''[[Penicillin G]] 4 mill. units IV q4h''''' ''OR'' '''''[[Ampicillin]] 2 gm q4h''''' ''OR'' '''''[[Moxifloxacin]] 400 mg IV | |||
q24h''''' ''OR'' '''''[[Chloro]] 1 gm IV q6h''''' | |||
|- | |||
| '''''1.>50 yrs 2.alcoholism 3.debilitating assoc diseases 4.impaired cellular immunity''''' || '''''[[Streptococcus pneumoniae]]'''''<BR>'''''[[listeria]]'''''[[Gram-negative|Gram-negative bacilli]]''''' ||'''''[[Ampicillin]] 2 gm IV q4h ''''' <BR>''PLUS''<BR>''''''[[Ceftriaxone]] 2 gm IV q12h''''' OR '''''[[Cefotaxime]] 2 gm IV q6h''''' <BR> ''PLUS'' <BR> '''''[[Vancomycin]]'''''<BR> ''PLUS''<BR>'''''IV [[Dexamethasone ]]''''' | |||
|| '''''[[Meropenem]] 2 gm IV q8h''''' <BR> ''PLUS''<BR> '''''[[Vancomycin]]''''' <BR> ''PLUS'' <BR> IV '''''[[Dexamethasone ]]''''' | |||
|- | |||
| '''''Post-neurosurgery, post-head trauma, or post-cochlear implant || '''''[[Streptococcus pneumoniae]] most common, esp. if CSF leak.'''''<BR>Other:[[Staphylococcus aureus]], coliforms, [[Pseudomonas aeruginosa]]||'''''Vancomycin (until known not MRSA) 500–750 mg IV q6h2''''''<BR> ''PLUS'' <BR>'''''[[Cefepime]] or [[Ceftazidime]] 2 gm IV q8h'''''||'''''[[Meropenem]] 2 gm IV q8h'''''<BR> ''PLUS'' <BR> '''''[[Vancomycin]]1 gm IV q6–12h ''''' | |||
|- | |||
| Ventriculitis/meningitis due to infected ventriculo-peritoneal (atrial) shunt||'''''[[Staphylococcus epidermidis]],'''''[[Staphylococcus aureus]],'''''coliforms,diphtheroids (rare),''''''[[Propionibacterium acnes]]'''''||'''''[[Vancomycin]] 500–750 mg IV q6h '''''<BR> ''PLUS''<BR>'''''[[cefepime]]''''' ''or'' '''''[[ceftazidime]] 2 gm IV q8h'''''||'''''[[Vancomycin]]''''' 500–750 mg IV q6h''''' <BR> ''PLUS''<BR>'''''[[Meropenem]]''''' 2 gm IV q8h ''''' | |||
|- | |||
|} | |||
====Positive CSF Gram Stain==== | ====Positive CSF Gram Stain==== |
Revision as of 04:24, 16 December 2013
Bacterial Meningitis
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Diagnosis
- Bacterial meningitis is the infection of meninges by bacteria.
Empiric Therapy
Negative CSF Gram Stain
Group | Etiology | Preferred Regimen | Alternative Regimen |
Preterm—1 mo | Streptococcus agalactiae (49%) Escherichia coli (18%) misc. Gram-positive (10%) misc. Gram-negative (10%) Listeria (7%) |
Ampicillin PLUS Cefotaxime (for dosage see footnote) |
Ampicillin PLUS Gentamicin (for dosage see footnote) |
1 mo—50 yrs | Streptococcus pneumoniae Neisseria meningitidis Haemophilus influenzae† |
Adult dosage:Cefotaxime 2 gm IV q4—6h OR Ceftriaxone 2 gm IV q12h PLUS Vancomycin 500—750 mg IV q6h‡ PLUS Dexamethasone 'Peds:'Cefotaxime 200 mg/kg per day IV div. q6–8h; Ceftriaxone 100 mg/kg per day IV div. q12h; Vancomycin 15 mg/kg IV q6h. |
Meropenem2 gm IV q8h PLUS Vancomycin PLUS IV Dexamethasone |
1.>50 yrs 2.alcoholism 3.debilitating assoc diseases 4.impaired cellular immunity | Streptococcus pneumoniae listeriaGram-negative bacilli |
Ampicillin 2 gm IV q4h PLUS 'Ceftriaxone 2 gm IV q12h OR Cefotaxime 2 gm IV q6h PLUS Vancomycin PLUS IV Dexamethasone |
Meropenem 2 gm IV q8h PLUS Vancomycin PLUS IV Dexamethasone |
Post-neurosurgery, post-head trauma, or post-cochlear implant | Streptococcus pneumoniae most common, esp. if CSF leak. Other: Staphylococcus aureus, coliforms, Pseudomonas aeruginosa |
Vancomycin (until known not MRSA) 500–750 mg IV q6h2' PLUS Cefepime or Ceftazidime 2 gm IV q8h |
Meropenem 2 gm IV q8h PLUS Vancomycin1 gm IV q6–12h |
Ventriculitis/meningitis due to infected ventriculo-peritoneal (atrial) shunt | Staphylococcus epidermidis,Staphylococcus aureus,coliforms,diphtheroids (rare),'Propionibacterium acnes | Vancomycin 500–750 mg IV q6h PLUS cefepime or ceftazidime 2 gm IV q8h |
Vancomycin 500–750 mg IV q6h PLUS Meropenem 2 gm IV q8h |
† H. influenzae now very rare, listeria unlikely if young & immuno-competent (add ampicillin if suspect listeria: 2 gm IV q4h)
‡ Children’s dosage 15 mg/kg IV q6h (2x standard adult dose). In adults, max dose of 2-3 gm/day is suggested: 500–750 mg IV q6h.
Postive CSF Gram Stain
Group | Etiology | Preferred Regimen | Alternative Regimen |
Gram-positive diplococci | S.pneumoniae | Ceftriaxone 2 gm IV q12h OR Cefotaxime 2 gm IV q4–6h PLUS Vancomycin 500–750 mg IV q6h PLUS timed Dexamethasone 0.15 mg/kg q6h IV x 2–4 days |
Meropenem 2 gm IV q8h OR Moxifloxacin 400 mg IV q24h |
Gram-negative diplococci | N. meningitidis | Cefotaxime 2 gm IV q4–6h OR Ceftriaxone 2 gm IV q12h | Penicillin G 4 mill. units IV q4h OR Ampicillin 2 gm q4h OR Moxifloxacin 400 mg IV
q24h OR Chloro 1 gm IV q6h |
1.>50 yrs 2.alcoholism 3.debilitating assoc diseases 4.impaired cellular immunity | Streptococcus pneumoniae listeriaGram-negative bacilli |
Ampicillin 2 gm IV q4h PLUS 'Ceftriaxone 2 gm IV q12h OR Cefotaxime 2 gm IV q6h PLUS Vancomycin PLUS IV Dexamethasone |
Meropenem 2 gm IV q8h PLUS Vancomycin PLUS IV Dexamethasone |
Post-neurosurgery, post-head trauma, or post-cochlear implant | Streptococcus pneumoniae most common, esp. if CSF leak. Other:Staphylococcus aureus, coliforms, Pseudomonas aeruginosa |
Vancomycin (until known not MRSA) 500–750 mg IV q6h2' PLUS Cefepime or Ceftazidime 2 gm IV q8h |
Meropenem 2 gm IV q8h PLUS Vancomycin1 gm IV q6–12h |
Ventriculitis/meningitis due to infected ventriculo-peritoneal (atrial) shunt | Staphylococcus epidermidis,Staphylococcus aureus,coliforms,diphtheroids (rare),'Propionibacterium acnes | Vancomycin 500–750 mg IV q6h PLUS cefepime or ceftazidime 2 gm IV q8h |
Vancomycin 500–750 mg IV q6h PLUS Meropenem 2 gm IV q8h |